# Bayer Opens Applications for G4A Accelerator Program in Health and Agriculture

> Bayer is inviting early-stage entrepreneurs in health and agriculture to apply for its G4A Startup Accelerator Program, offering funding and mentoring opportunities for scalable digital solutions.

Published: 2025-12-29T11:34:00+00:00
Language: en
Categories: [Pharmaceutical Industry](https://chemexworld.com/en/categories/sectors/pharmaceutical-industry-1.md), [Projects](https://chemexworld.com/en/categories/business-world-markets/projects.md), [News](https://chemexworld.com/en/categories/news.md)

Canonical URL:
https://chemexworld.com/en/news/bayer-opens-applications-for-g4a-accelerator-program-in-health-and-agriculture

## Content

Istanbul, December 26, 2025 – Applications for Bayer’s G4A Startup Accelerator Program will open on January 2 and remain available until February 1, 2026. The program, launched in collaboration with Tenity, has supported Turkey’s startup ecosystem since 2018 by fostering innovation in health and agriculture.

The G4A program is open to entrepreneurs offering **scalable, sustainable digital solutions** in the fields of health and agriculture. Eligible applicants must have moved beyond the idea stage and developed either a **minimal viable product (MVP), a working prototype, or already launched a product in the market**. Applications can be submitted via **g4a.bayer.com.tr**, where detailed focus areas are also listed.

Each selected startup will receive **grant funding of 500,000 TL**, provided certain requirements are met*.

Bayer’s G4A Program Manager, **Melis Soylu**, commented on the new program cycle, stating:
**"This year, we are united under a single theme: transforming technology into functional, value-creating solutions. In healthcare, our focus is on innovative digital communication models and next-generation distribution channels that improve access to products, patients, healthcare professionals and consumers. We are also interested in solutions that enhance the patient journey and enable early diagnosis and treatment. In agriculture, we are prioritizing startups that use data-driven decision-making to increase efficiency, apply variable-rate technologies based on field conditions, develop new equipment or improve existing systems. In both sectors, we are looking for innovations that make sense of data, simplify life, and deliver measurable benefits."**

**![bayer-content](https://chemexworld.com/storage/uploads/GvHJL0ZcH1WFQWQZqFULudfEADl55Ehe73le3Nsg.jpg)**

Entrepreneurs across Türkiye can also participate in a **live online event on January 21, 2026**, to ask questions and learn more about the program. All announcements and registration links will be available via **Bayer’s social media channels** (Facebook, Instagram, LinkedIn and YouTube).

Selected startups will participate in a **100-day acceleration program**, which includes online training sessions covering topics such as business model development, sales strategies, go-to-market planning and presentation skills. They will also benefit from **mentorship by industry experts**, including Bayer employees, and will have the opportunity to **collaborate with Bayer**, expand their networks and improve their products. Grant funding of **500,000 TL** will be awarded to selected participants*.

Over the past eight years, Bayer’s G4A Accelerator has supported **47 startups** with nearly **10 million TL** in funding, mentorship, training, networking and collaboration opportunities. Among these, **17 startups** have gone on to generate sales, secure investments, or enter international markets. Their **combined valuation** has now reached **172 million USD**.

*Note: Entrepreneurs selected for grant funding must establish a legal business entity (such as a limited liability company) to receive the financial support.

---

### **About Bayer**

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Guided by its mission “Health for All, Hunger for None,” the company aims to address the major challenges of a growing and aging global population through innovative products and services that benefit people and the planet. Bayer is committed to sustainable development and to making a meaningful impact in the areas where it operates. The Bayer brand is recognized worldwide as a symbol of trust, quality and reliability.

As of fiscal year 2024, Bayer employed approximately **93,000 people** and generated sales of **46.6 billion euros**. The company’s R&D investment totaled **6.2 billion euros**.
More information is available at [www.bayer.com.tr](https://www.bayer.com.tr).